LIQUIDIA CORPORATION Shares Outstanding (Cover Page)
LIQUIDIA CORPORATION (LQDA) had Shares Outstanding (Cover Page) of 89.51 million shares as of 2026-07-29, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-07-29: Entity Common Stock, Shares Outstanding 89.51M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 88.93M shares.
- 2026-02-17: Entity Common Stock, Shares Outstanding 88.11M shares.
- 2025-10-20: Entity Common Stock, Shares Outstanding 87.00M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-29 | 89.51M shares 10-Q · filed 2026-08-12 |
| 2026-05-01 | 88.93M shares 10-Q · filed 2026-05-11 |
| 2026-02-17 | 88.11M shares 10-K · filed 2026-03-05 |
| 2025-10-20 | 87.00M shares 10-Q · filed 2025-11-03 |
| 2025-08-04 | 86.09M shares 10-Q · filed 2025-08-12 |
| 2025-05-01 | 85.48M shares 10-Q · filed 2025-05-08 |
| 2025-03-10 | 85.30M shares 10-K · filed 2025-03-19 |
| 2024-10-30 | 84.64M shares 10-Q · filed 2024-11-13 |
| 2024-08-01 | 76.79M shares 10-Q · filed 2024-08-07 |
| 2024-05-02 | 76.38M shares 10-Q · filed 2024-05-13 |
| 2024-03-11 | 76.03M shares 10-K · filed 2024-03-13 |
| 2023-11-01 | 64.91M shares 10-Q · filed 2023-11-07 |
| 2023-08-01 | 64.74M shares 10-Q · filed 2023-08-10 |
| 2023-05-01 | 64.72M shares 10-Q · filed 2023-05-08 |
| 2023-03-02 | 64.69M shares 10-K · filed 2023-03-20 |
| 2022-11-01 | 64.49M shares 10-Q · filed 2022-11-08 |
| 2022-08-01 | 64.36M shares 10-Q · filed 2022-08-11 |
| 2022-05-03 | 64.34M shares 10-Q · filed 2022-05-12 |
| 2022-03-04 | 52.44M shares 10-K · filed 2022-03-17 |
| 2021-10-28 | 51.98M shares 10-Q · filed 2021-11-03 |
| 2021-08-04 | 51.98M shares 10-Q · filed 2021-08-10 |
| 2021-05-04 | 51.97M shares 10-Q · filed 2021-05-13 |
| 2021-03-15 | 43.34M shares 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |